• TechCrunch
• CrunchBase
• More
  • TechCrunch UK
  • TechCrunch France
  • TechCrunch Japan

Aragon Pharmaceuticals

edit

Aragon Pharmaceuticals is a discovery-stage small molecule company focused on therapeutics for the treatment of hormone-resistant cancers, with an initial focus on prostate and breast cancer.

Milestones

edit

• 
  Aragon Pharmaceuticals received $22M in Series B funding. (4/22/10)
  Posted 4/22/10 at 9:31am via fiercebiotech.com
• 
  Aragon Pharmaceuticals received $8M in Series A funding. (5/27/09)
  Posted 6/17/09 at 1:23pm via onbiovc.com

Videos

Screenshots

edit

Above: Aragon0609
Uploaded: 6/17/09

Sources

1. Aragon Pharmaceuticals, Inc.: Series A $8M (onbiovc.com) [edit]
2. Aragon Pharma readies first cancer trial after $22M B round (fiercebiotech.com) [edit]